Preoperative Antiseptic in Newborn Circumcision Comparison of Povidone Iodine and Hypochlorous Acid Used
"Comparison of Povidone Iodine and Hypochlorous Acid Used as a Preoperative Antiseptic in Neonatal Circumcision"
1 other identifier
interventional
60
1 country
1
Brief Summary
Comparison of Povidone iodine and Hypochlorous acid used as a Preoperative Antiseptic in Newborn Circumcision abstract Aim: Circumcision is one of the most common surgical procedures in all age groups. Before the circumcision procedure, asepsis is provided with a surface disinfectant. Various methods can be used for this process. Povidone iodine, which has been used for years during the transition from traditional circumcision methods to surgical circumcision methods; tissue damage, allergic reactions and increase in pain level. For this reason, the investigators aimed to compare it with Hypochlorous acid (Crystalin), which is a less toxic and more physiological antiseptic solution. Material and Method: Newborns to be circumcised randomly were divided into two groups as Hypochlorosis group and Povidone iodine group. At the beginning of the circumcision procedure, a culture was taken in the form of a prepucial swab 1 minute after the cleaning of the local area and the inner surface of the prepuce. Then circumcision was performed. Culture results and complications were compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2021
CompletedFirst Submitted
Initial submission to the registry
November 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2021
CompletedFirst Posted
Study publicly available on registry
January 3, 2022
CompletedJanuary 3, 2022
December 1, 2021
6 months
November 11, 2021
December 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The effect of both drugs on wound healing will be investigated.
there is wound healing;1,no wound healing:0
one month
The effect of both drugs on antibacterial effects will be investigated
there is bacterial growth:1, there is no bacterial growth:0
one week
Study Arms (2)
Hypochlorosis
ACTIVE COMPARATORHypochlorosis was used as an antiseptic for the patients
Povidone iodine
ACTIVE COMPARATORPovidone iodine was used as an antiseptic for the patients
Interventions
Eligibility Criteria
You may qualify if:
- male
- newborn,
You may not qualify if:
- hipospadias,
- epispadias,
- urinary infectious
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hisar Intercontinental Hospital
Istanbul, 34768, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Basri Cakiroglu
Hisar Intercontinental Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass. Prof.
Study Record Dates
First Submitted
November 11, 2021
First Posted
January 3, 2022
Study Start
May 5, 2021
Primary Completion
October 30, 2021
Study Completion
November 11, 2021
Last Updated
January 3, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share